Results 191 to 200 of about 194,741 (300)

How Much to Sell and When: Optimal Staged Divestiture of Patent‐Linked Royalty Claims Under Risk, Illiquidity, and Finite Horizon

open access: yesManagerial and Decision Economics, EarlyView.
ABSTRACT Patent owners can sell a royalty interest in stages rather than all at once. This paper asks how much to sell now when claim values are uncertain, buyers are costly to reach, and patent expiry limits the time available. A decision model produces sale schedules that adjust to current value, the share retained, and time remaining.
Andreas Peters
wiley   +1 more source

Weak SLP-76/PLC-γ1 interaction fine-tunes T cell receptor signal strength to optimize T cell responsiveness. [PDF]

open access: yesNat Commun
Yamane H   +15 more
europepmc   +1 more source

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta‐Analysis

open access: yesMovement Disorders, EarlyView.
Abstract Background Variants in GBA1 are important genetic risk factors for synucleinopathies, including Parkinson's disease (PD). Although several GBA1 variants are established risk or severity modifiers, the role of the p.E427K variant remains unclear.
Leah V. Chifamba   +30 more
wiley   +1 more source

Rare‐Variant Burden Analysis of Dystonia Genes in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Dystonia frequently coexists with Parkinson's disease (PD), yet the extent of genetic overlap remains insufficiently explored. Objective The aim was to examine whether rare variants in dystonia‐related genes are associated with PD or early‐onset PD (EOPD).
Sajanth Kanagasingam   +4 more
wiley   +1 more source

Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1‐Associated Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Individuals with Parkinson's disease (PD) carrying GBA1 variants often develop advanced motor complications that prompt evaluation for deep brain stimulation (DBS). However, concerns about accelerated cognitive decline after DBS in GBA1 carriers complicate clinical decision making.
Evridiki Asimakidou   +61 more
wiley   +1 more source

Home - About - Disclaimer - Privacy